Effects of administration of iron isomaltoside 1000 in patients with chronic heart failure. A pilot study
- 17 November 2010
- journal article
- Published by Wiley in Transfusion Alternatives in Transfusion Medicine
- Vol. 11 (4), 131-137
- https://doi.org/10.1111/j.1778-428x.2010.01145.x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Ferric Carboxymaltose in Patients with Heart Failure and Iron DeficiencyThe New England Journal of Medicine, 2009
- EVOLUTION OF IV IRON COMPOUNDS OVER THE LAST CENTURYJournal of Renal Care, 2009
- Anemia and Chronic Heart Failure: Implications and Treatment OptionsJournal of the American College of Cardiology, 2008
- Effect of Intravenous Iron Sucrose on Exercise Tolerance in Anemic and Nonanemic Patients With Symptomatic Chronic Heart Failure and Iron Deficiency: FERRIC-HF: A Randomized, Controlled, Observer-Blinded TrialJournal of the American College of Cardiology, 2008
- Intravenous Iron Reduces NT-Pro-Brain Natriuretic Peptide in Anemic Patients With Chronic Heart Failure and Renal InsufficiencyJournal of the American College of Cardiology, 2007
- Etiology of Anemia in Patients With Advanced Heart FailureJournal of the American College of Cardiology, 2006
- Intravenous Iron Alone for the Treatment of Anemia in Patients With Chronic Heart FailureJournal of the American College of Cardiology, 2006
- Update on adverse drug events associated with parenteral ironNephrology Dialysis Transplantation, 2005
- On the relative safety of parenteral iron formulationsNephrology Dialysis Transplantation, 2004
- Anemia Is Common in Heart Failure and Is Associated With Poor OutcomesCirculation, 2003